The inactivation of human plasma alpha 1-proteinase inhibitor by proteinases from Staphylococcus aureus.
The interaction of three proteinases (seryl, cysteinyl, and metallo-) from Staphylococcus aureus with human plasma alpha 1-proteinase inhibitor has been investigated. As expected, none of the enzymes was inactivated by this protein, each, instead causing the conversion of the native inhibitor into an inactive form of decreased molecular weight. Amino-terminal sequence analysis indicated that inhibitor inactivation had occurred by peptide bond cleavage near the reactive center of this protein. When the inhibitor was modified by this treatment, it became resistant to both pH and temperature denaturation and, in contrast to the intact denatured protein, did not undergo further proteolytic degradation. This process of inactivation of alpha 1-proteinase inhibitor by pathogenic proteinases could result in a deregulation of its target enzyme, neutrophil elastase, and, therefore, may be important in the consumption of some plasma proteins by this enzyme during septicemia.
D000595:Amino Acid Sequence; D001798:Blood Proteins / Q000037:antagonists & inhibitors*; D004305:Dose-Response Relationship, Drug; D004591:Electrophoresis, Polyacrylamide Gel; D010450:Endopeptidases / Q000378:metabolism; D006801:Humans; D008666:Metalloendopeptidases; D010447:Peptide Hydrolases / Q000378:metabolism*; D011489:Protein Denaturation; D013211:Staphylococcus aureus / Q000201:enzymology*; D013997:Time Factors; D000515:alpha 1-Antitrypsin
D001798:Blood Proteins; D000515:alpha 1-Antitrypsin; D010450:Endopeptidases; D010447:Peptide Hydrolases; D008666:Metalloendopeptidases